With approximately 500 million Arabs residing in the 22 Arab countries and an estimated 4. million (depending on who’s counting) residing in the United States1,2,3, this diverse group of people linked by their ethnicity, language, culture, and other factors accounts for a not-so-tiny part of the human race. And while they represent just 1.5% of the U.S. population — and African Americans and Hispanics represent roughly 14% and 19%, respectively — there are several justifications for advocating for their distinct inclusion in clinical trials.
“The primary objective of the ADC-RI Media Research Project is to research, track, and document anti-Arab and Islamophobic bias in the media, public discourse, and from public officials. This tracking project will serve as a resource tool which will highlight the prevalence of bias and bigotry. The project will expose xenophobia and hatred that target minorities in the U.S., particularly Arab and Muslim Americans.
The project will also celebrate achievements of Arabs and Muslims from around the world.”
